Melhores Consulta Online com Oncologista médicos - TOP-66 médicos

O Dr. Mustafa Solak é um oncologista médico especializado em cânceres de mama, testículo, ovário, pulmão, cabeça-pescoço e gastrointestinal. Ele se formou na Faculdade de Medicina da Universidade de Hacettepe. Completou sua residência no Hospital de Ensino e Pesquisa Sisli Etfal de Istambul. Em seguida, fez uma bolsa de especialização no Instituto de Câncer da Universidade de Hacettepe.

O Dr. Solak geriu muitos casos complexos de câncer. Ele contribuiu para avanços clínicos em centros respeitados, incluindo o MD Anderson Cancer Center da Universidade do Texas. Também trabalhou no Hospital de Treinamento de Hitit University Corum e no Hospital Medical Park. Sua experiência demonstra um forte compromisso com o cuidado e a pesquisa do câncer.

O Prof. Dr. Tayfun Apuhan é especialista em Otorrinolaringologia e Cirurgia de Cabeça e Pescoço. Ele é conhecido pela sua habilidade no tratamento de infecções de ouvido, reparação da membrana timpânica e realização de rinoplastia e septorrinoplastia. Ele também tem experiência em adenoidectomia, amigdalectomia, cirurgia de apneia do sono, microcirurgia das cordas vocais e cirurgia de tumor de cabeça e pescoço. O Dr. Apuhan fundou o Departamento de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço no Özel A Plus Hisar Intercontinental Hospital.

O Dr. Apuhan obteve seu diploma de medicina na Universidade İnönü. Ele completou formação adicional na Universidade Abant Izzet Baysal, Centro Médico Universitário de Hamburgo-Eppendorf, Universidade Gazi e Centro Oncológico Abrangente da Universidade Estadual de Ohio. Ele publicou mais de 200 artigos científicos. Ele também atuou como presidente de sessão e editor em conferências e revistas internacionais. Atualmente, o Dr. Apuhan lidera o programa de audiometria na Universidade Doğuş.

Prof. Yeşim (Yesim) Yıldırım — Oncologista Médica no Centro Médico Anadolu (desde 2011). Especialista certificado pela ESMO, Professora desde 2021, autora de mais de 80 publicações científicas. Formada em centros de excelência — Rambam (Israel) e Mount Vernon (Reino Unido). Trata cânceres de mama, pulmão e gastrointestinais (GI), além de melanoma e sarcomas; utiliza imunoterapia e terapia direcionada.

Por que os pacientes escolhem a Dr.ª Yeşim Yıldırım:

• Mais de 20 anos de prática clínica; Professora de Oncologia Médica desde 2021.
• Mais de 80 publicações revisadas por pares em biologia tumoral, imunoterapia e terapia direcionada — planos de tratamento baseados em evidências atualizadas.
• Certificação ESMO — da principal sociedade europeia de oncologia — confirma alta qualificação e formação contínua de acordo com os padrões internacionais.

Dr. Suleyman Hilmi Aksoy was born in 1974. He graduated from Istanbul University Çapa School of Medicine in 1998. He completed his residency in Radiodiagnostics and Interventional Radiology at Cerrahpaşa School of Medicine in 2002.

He has given oral and written presentations at 13 local and international congresses. Dr. Aksoy specializes in Diagnostic Radiology, Teleradiology, and Interventional Radiology. He has made important contributions in these areas.

He has worked at Hisar Intercontinental Hospital, Merzifon Air Hospital, Istanbul Emar Center, and Haseki Training and Research Hospital. Dr. Aksoy is dedicated to improving radiological practices.

Dr. Rahib Hasanov is a medical oncologist. He graduated from Istanbul University Cerrahpaşa Faculty of Medicine (1999–2005). He completed an internal medicine residency (2009–2013) and a medical oncology fellowship at Marmara University (2015–2018). He also completed an observership at Houston Methodist Hospital (2006–2007).

He focuses on personalized oncology. His treatments include immunotherapy, targeted therapy, and novel agents. His clinical interests include gastrointestinal, breast, lung, and genitourinary cancers.

He attends national and international conferences. He welcomes patients from Turkey, Azerbaijan, Montenegro, Georgia, Uzbekistan, the Middle East, Europe, and the United States.

Dr. Lana Bijelic is a board-certified oncological surgeon. She specializes in peritoneal carcinomatosis. Since 2019, she has been part of the Carcinomatosis Surgical Group at the Teknon Oncology Institute. She trained under Prof. Paul Sugarbaker at Washington Hospital Center and brings strong expertise to her team.

Dr. Bijelic has worked as Research Director at Inova Fairfax Hospital. She has also been an associate professor at Virginia Commonwealth University and Georgetown University. She is an active member of the American College of Surgeons and the Society of Surgical Oncology.

Throughout her career, Dr. Bijelic has received many academic awards, including several Surgical Excellence Awards and top prizes in research. She is known for her leadership and important contributions to surgical oncology.

Um dos melhores especialistas em câncer na Europa, educador e pesquisador de câncer, Presidente do Central European Cooperative Oncology Group (CECOG).
Publicou mais de 600 artigos científicos sobre o tratamento do câncer.

Experience

• 1990 - 1994 – General Practitioner
• 1994 - 2001 – Research Assistant, Erciyes University, Faculty of Medicine
• 2001 - 2006 – Assistant Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2006 - 2011 – Associate Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine
• 2011 - 2019 – Professor, Internal Medicine/Hematology, Erciyes University, Faculty of Medicine

Professional Memberships

• Turkish Society of Hematology
• European Group for Blood and Marrow Transplantation (EBMT)
• Hematologic Oncology Association
• Antalya Medical Chamber

Kodchanut Litleaungdej, M.D.

Activities • Prevention, research and early diagnosis of cancer • Palliative care in cancer • Cytotoxic chemotherapy • Hormontherapy • Targeted treatment • Immunotherapy Education • 2004 -2010 - Istanbul University, Istanbul faculty of medicine • 2011-2015 - Istanbul University, Istanbul faculty of medicine, internal medicine specialist • 2013-2014 - Cleveland Clinic Endocrinology Department, research associate • 2016-2019 Bezmiâlem Foundation University Medical Oncology Subdivision • Dissertation: Prognostic value of absolute monocyte count in patients with mantle cell lymphoma. • Subdivision Dissertation: An effect of adjuvant chemotherapy on lipid profile and anthropometric parameters in patients with breast and colon cancer. Publications • Circulating Thyroid-Stimulating Hormone Receptor Messenger RNA as a Marker of Tumor Aggressiveness in Patients with Papillary Thyroid Microcarcinoma. Aliyev A, Gupta M, et al. Endocr  18. • The utility of peripheral thyrotropin receptor mRNA in the management of differentiated thyroid cancer. • Aliyev A, Soundararajan S, Bucak E et al. Surgery.  • Diagnostic accuracy of circulating thyrotropin receptor messenger RNA combined with neck ultrasonography in patients with Bethesda III-V thyroid cytology. Aliyev A, Patel J, Brainard J, et al. Surgery.2016 Jan;159(1):113-7. doi: 10.1016/j.surg.2015.06.063. Epub 2015 Oct 9. • Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients. Seker M, Aliyev A, et al. Oncol Res Treat. Epub 2018 Aug 20. • Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes. Esin E, Oksuzoglu B, Bilici A, Aliyev A. Cancer Chemother Pharmacol.2019 Jan; Epub 2018 Oct 30. • Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer. Turk HM, Aliyev A, Celik RS. Curr Probl Cancer.2019 Jul 29. pii: currproblcancer.2019.06.009. • Prognostic impact of primary tumor location on survival in metastatic colorectal cancer patients: A single center experience. Tarik Demir, Murat Araz, Altay Aliyev. Medicine Science International Medicine Journal. • Oral presentations 

Dr. Selime Aydogdu is a specialist in pediatric hematology and oncology. She is known for her work in improving early cancer detection in children. Dr. Aydogdu has given many presentations and led discussions on recognizing early cancer symptoms. Her efforts have raised awareness in her field.

Her work has helped achieve better diagnostic results and higher survival rates for children. Dr. Aydogdu is dedicated to education and advocacy. She is a respected member of the pediatric oncology community.

Education and Specialization

• Faculty of Medicine, Hacettepe University
• 1999 - Akdeniz University, Faculty of Internal Medicine, Internal Medicine Specialization Training
• Internal Medicine Specialization Training in the USA, Akdeniz University (2013 - 2014)
• Internal Medicine Specialization Training in the USA (2013 - 2014) - Medical Oncology Department
• Akdeniz University, Faculty of Medicine, Department of Medical Oncology (Received Associate Professorship title)

Work Experience

• 2009 - Kayseri Training and Research Hospital, Hospital
• Acıbadem Kayseri
• 2017 - 2018 - Lara Private Anadolu Hospital
• 2018 - Medical Park Antalya Hospital Complex

Expertise

• Diagnosis of organ tumors
• Chemotherapy in cancer treatment
• Targeted cancer therapies
• Immunotherapy in cancer treatment
• Next-generation genetic research in cancer treatment
• Complementary medicine in cancer treatment
• Medical oncology

Dr. Auala Hubert is a board-certified medical oncologist and radiotherapist with 33 years of clinical experience. She works at Hadassah Medical Center and speaks both English and Hebrew. Dr. Hubert leads the Gastrointestinal Cancer Center. She is also a senior physician in the Oncology Department.

She earned her M.D. from Hadassah University Hospital. She holds board certifications in oncology and radiotherapy. Dr. Hubert has passed USMLE Parts I and II. She is a member of the Israel Society of Clinical Oncology, Israel Medical Society, and Israel Cancer Association. Dr. Hubert also serves on several medical and social service committees, where she helps advance cancer care.

Personal Information 

Sex:  Male

Born : 1968 

Professional Experience

Gayrettepe Florence Nigthingale Hospital

Medical Oncology Department

Besiktas/Istanbul/Turkey (ongoing)

Education:

He became Professor (22/April /2016)

Medical Oncology

Attending Phys.in Gastrointestinal Oncology (January 2005 ,2009)

Istanbul University Oncology Institue,

Department of Medical Oncology

Medical Oncology Fellowship (December 2001-December2004)

Istanbul University, Istanbul Medical Faculty

Hemodialysis Traning (May1996-January1997)

Istanbul University ,bCerrahpasa Medical Faculty

Internal Medicine Residency (November 1991-November 1996)

Istanbul University ,bCerrahpasa Medical Faculty

Ege University Medical Faculty (1985-1991)

Professional Experience

February 1999-November 2001

Metropolitan Florence Nigthingale Hospital

American Cancer Center, Gayrettepe/İstanbul

April1997- October 1998

Bayraktar Dialysis Center

Güngören/ Istanbul

Membership

Turkish Medical Oncology Association

ENET(European Neuroendocrine Tumour Society)

ESMO

ASCO

Dr. Enriqueta Felip is an expert in thoracic oncology. She specializes in lung cancer care and clinical trials. She earned her medical degree and PhD from UAB. Dr. Felip has led research on improving chemotherapy, developing new therapies, using immunotherapy, and understanding resistance to targeted treatments.

She served as a board member of the IASLC from 2017 to 2021 and was Vice-President of SEOM from 2019 to 2021. In 2015, she received the first ESMO Women for Oncology Award. Dr. Felip has written many peer-reviewed articles and book chapters. She is known for her leadership in international oncology societies and clinical research.

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

Experience

2022 PRIVATE MEDIPOL BAHÇELİEVLER HOSPITAL

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital, Medical Oncology Clinic Education Officer

2021 - 2021 Prof. Dr. Cemil Taşçıoğlu City Hospital

2020 - 2021 Yüzüncü Yıl University Faculty of Medicine

2020 - 2021 Head of the Department of Medical Oncology, Yüzüncü Yıl University Faculty of Medicine, Assoc. Dr.  

2018 - 2021 Lecturer - Yüzüncü Yıl University Faculty of Medicine, Head of Medical Oncology Department  

2018 - 2021 Yüzüncü Yıl University Faculty of Medicine

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital

2015 - 2018 University of Health Sciences, Okmeydanı Training and Research Hospital, Medical Oncology Clinic, Sub-branch assistant

2012 - 2015 Kanuni Sultan Süleyman Training and Research Hospital, Internal Medicine specialist

2012 - 2015 Suleiman the Magnificent Training and Research Hospital,

2008 - 2012 Haseki Training and Research Hospital

2006 - 2008 Kızıltepe No. 3 Health Center General Practitioner.

Education

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2018

İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji, İstanbul Okmeydanı Eğitim ve Araştırma Hastanesi, Tıbbı Onkoloji

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları, İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2012

İstanbul Haseki Eğitim ve Araştırma Hastanesi, İç Hastalıkları

2007

Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi, Uludağ Üniversitesi Tıip Fakültesi, Tıip Fakültesi

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.